Author

S. K. McBride

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

F. G. Tafesse· 3 shared T. A. Bates· 2 shared A. Olive· 1 shared A. R. McDonald· 1 shared A. Worley· 1 shared C. A. Kulicke· 1 shared C. Lemon· 1 shared C. M. Heisler· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

F. G. Tafesse

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Diverging maternal and infant cord antibody functions from SARS-CoV-2 infection and vaccination in pregnancy

E. H. Adhikari, P. Lu, Y. J. Kang, A. R. McDonald, J. E. Pruszynski, T. A. Bates, S. K. McBride, M. Trank-Greene, F. G. Tafesse, L. L. Lu

This study compares maternal and infant cord antibody responses to SARS-CoV-2 infection and vaccination during pregnancy, finding differences in neutralizing activity, Fc effector functions, and glycosylation patterns.

bioRxiv · May 1, 2023Immunology

Delivery of loaded MR1 Monomer Results in Efficient Ligand Exchange to Host MR1 and Subsequent MR1T cell activation

C. A. Kulicke, G. M. Swarbrick, N. A. Ladd, M. Cansler, M. Null, A. Worley, C. Lemon, T. Ahmed, J. Bennett, T. N. Lust, C. M. Heisler, M. E. Huber, J. R. Krawic, L. M. Ankley, S. K. McBride, , M. J. Harriff

The paper demonstrates that delivering MR1 monomers loaded with 5-OP-RU enables ligand exchange to host MR1, leading to MR1T cell activation.

bioRxiv · Jul 11, 2022Immunology

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants

J. B. Weinstein, T. A. Bates, H. C. Leier, S. K. McBride, E. Barklis, F. G. Tafesse

This paper describes a potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants with high efficacy and stability.

bioRxiv · Jan 18, 2022Immunology